The majority of GRN mutations are loss-of-function [24] and account for 5–20% of familial FTD cases and 1–5% of apparently sporadic FTD [6], giving rise to Type A FTLD-TDP neuropathology [49]. The gene discussed is GRN; the disease is frontotemporal dementia.